The SenSzi (GBG80) Trial 1 has assessed the contribution of information derived from lymphoscintigraphy in improving the performance of the sentinel lymph node (SLN) biopsy procedure in cN0 breast ...

Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has ...

In the trials that served to establish the SLNB procedure, the false-negative rate varied between 5.5% and 16.7%, and the lowest false-negative rates were from studies in which preoperative ...

The sentinel lymph node (SLN) is the lymph node that represents the 'gate-keeper' of the lymphatic basin; it is the first node to receive lymphatic drainage from the site of the primary tumor. SLN ...

Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...

IntroductionLymph node involvement significantly impacts the prognosis of patients with gynecologic cancers, such as vulvar and cervical cancers. Traditional extensive lymph node dissection is ...